Atlas Trials

A Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's Disease

Clinical trial NCT00087724 · TERMINATED

Trial details

NCT number
NCT00087724
Sponsor
Astellas Pharma Inc
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2004-07-01
Enrollment
510

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.